Search

West Pharmaceutical Services Inc

Открыт

СекторЗдравоохранение

370.22 -0.82

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

368.69

Макс.

382.23

Ключевые показатели

By Trading Economics

Доход

15M

154M

Продажи

27M

872M

P/E

Средняя по отрасли

46.204

55.725

Прибыль на акцию

2.37

Дивидендная доходность

0.24

Рентабельность продаж

17.654

Сотрудники

10,800

EBITDA

-39M

179M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+10.31% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

0.24%

2.25%

Следующий отчет о доходах

22 окт. 2026 г.

Дата следующей выплаты дивидендов

18 нояб. 2026 г.

Следующая эксдивидендная дата

11 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

570M

25B

Предыдущая цена открытия

371.04

Предыдущая цена закрытия

370.22

Новостные настроения

By Acuity

100%

0%

307 / 339 Рейтинг в Healthcare

West Pharmaceutical Services Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

24 сент. 2026 г., 22:40 UTC

West Pharmaceutical Services Inc declined in after-hours trading, reversing an initial gain, despite remaining above its 20-day moving average.

23 сент. 2026 г., 23:51 UTC

West Pharmaceutical Services Inc is seeing a modest decline in after-market trading, positioned at the lower end of today's range but above its 20-day moving average.

22 сент. 2026 г., 20:02 UTC

News

Morgan Stanley upgraded West Pharmaceutical Services Inc to Overweight and raised its price target to $400, contributing to a significant rise in the stock.

18 сент. 2026 г., 20:03 UTC

West Pharmaceutical Services Inc shares fell sharply, reversing from an earlier peak to drop to their lowest point late in the morning amid a broader decline.

17 сент. 2026 г., 22:41 UTC

West Pharmaceutical Services Inc is experiencing a modest decline in after-market trading, moving lower alongside the broader market's significant downward movement.

16 сент. 2026 г., 20:13 UTC

West Pharmaceutical Services Inc is advancing in after-market trading, significantly above its 20-day moving average since Wednesday's close.

15 сент. 2026 г., 20:13 UTC

West Pharmaceutical Services shares are lower in after-market hours amid negative market sentiment and concerns over economic momentum and potential interest rate hikes.

14 сент. 2026 г., 20:07 UTC

News

West Pharmaceutical Services is gaining as CFO discusses strong second-quarter results at the Morgan Stanley conference, despite a recent cyber incident.

11 сент. 2026 г., 20:01 UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

10 сент. 2026 г., 20:51 UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

9 сент. 2026 г., 20:07 UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

8 сент. 2026 г., 23:26 UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

4 сент. 2026 г., 19:36 UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

3 сент. 2026 г., 22:01 UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2 сент. 2026 г., 23:51 UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

1 сент. 2026 г., 23:51 UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

31 авг. 2026 г., 20:07 UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

28 авг. 2026 г., 23:11 UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

27 авг. 2026 г., 23:02 UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

26 авг. 2026 г., 19:26 UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

25 авг. 2026 г., 23:26 UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

24 авг. 2026 г., 19:51 UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

21 авг. 2026 г., 23:01 UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

20 авг. 2026 г., 20:06 UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

19 авг. 2026 г., 20:06 UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

18 авг. 2026 г., 19:36 UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

17 авг. 2026 г., 22:55 UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

14 авг. 2026 г., 23:01 UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

13 авг. 2026 г., 23:36 UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

12 авг. 2026 г., 19:36 UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

Сравнение c конкурентами

Изменение цены

West Pharmaceutical Services Inc Прогноз

Целевая цена

By TipRanks

10.31% рост

Прогноз на 12 месяцев

Средняя 412.111 USD  10.31%

Максимум 447 USD

Минимум 390 USD

Основано на мнении 10 аналитиков Wall Street, спрогнозировавших целевые цены для West Pharmaceutical Services Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

10 ratings

10

Покупка

0

Удержание

0

Продажа

Настроения

By Acuity

307 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства нисходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.